Minimize Menorrhagia in Women With Von Willebrand Disease
Public ClinicalTrials.gov record NCT02606045. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize Study
Study identification
- NCT ID
- NCT02606045
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Margaret Ragni
- Other
- Enrollment
- 39 participants
Conditions and interventions
Conditions
Interventions
- recombinant von Willebrand factor Drug
- tranexamic acid Drug
Drug
Eligibility (public fields only)
- Age range
- 13 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 6, 2019
- Primary completion
- Apr 29, 2022
- Completion
- Aug 29, 2022
- Last update posted
- Jun 30, 2024
2019 – 2022
United States locations
- U.S. sites
- 19
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Center for Inherited Blood Disorders (CIBD) | Orange | California | 92868 | — |
| University of California San Francisco | San Francisco | California | 94117 | — |
| Emory University Afflac Blood Disorders Center | Atlanta | Georgia | 30322 | — |
| Henry Ford Hospital Medical Center | Detroit | Michigan | 48202 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| Mayo Clinic | Rochester | Minnesota | 55902 | — |
| Washington University St. Louis | St Louis | Missouri | 63110 | — |
| Cure4thekids Foundation | Las Vegas | Nevada | 89135 | — |
| Rutgers Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| State University of New York Upstate Medical Center | Syracuse | New York | 13210 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Pittsburgh and Hemophilia Center Western PA | Pittsburgh | Pennsylvania | 15213 | — |
| Vanderbilty University | Nashville | Tennessee | 37322 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| Bloodworks Northwest | Seattle | Washington | 98104 | — |
| Versiti Blood Center of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02606045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02606045 live on ClinicalTrials.gov.